rs769383881

Variant summary

Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PS4_ModeratePP1_StrongPM1PM3PM2PP4

This summary comes from the ClinGen Evidence Repository: The NM_000527.5(LDLR):c.337G>A (p.Glu113Lys) variant is classified as Pathogenic for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PP1_Strong, PM1, PM2, PM3, PS4_Moderate and PP4 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 23 February 2024. The supporting evidence is as follows:PM2: PopMax MAF = 0.0001 (0.01%) in South Asian (gnomAD v4.0.0). PM1: Variant meets PM2 and is missense in exon 4.PS4_Moderate, PP4: Variant meets PM2 and is identified in at least 8 unrelated index cases who fulfill criteria for FH (1 case with possible FH by Simon Broome criteria from the Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, Czech Republic; 1 case with possible FH by Simon Broome criteria and 1 case with DLCN score >=6 from Service de Biochimie de Biologie Moléculaire, Hospices Civils de Lyon, France; 1 case with possible FH by Simon Broome criteria from PMID 17539906 (Taylor et al., 2007), UK; 1 case with DLCN score >=6 from PMID 16250003 (Fouchier et al., 2005), The Netherlands; 1 case with possible FH by Simon Broome criteria from PMID 10807540 (Wu et al., 2000), USA; 2 cases with definite FH by Simon Broome criteria from PMID 34456049 (Marco-Benedi et al., 2022). PP1_Strong: Variant segregates with FH phenotype in 8 informative meioses in 1 family in PMID:10807540 (Wu et al., 2000), USA: 7 affected family members have the variant.PM3: Variant meets PM2 and is identified in an index case with a homozygous FH phenotype (10 yo with LDLc= 14.9 mmol/L); variant is in compound heterozygosity with c.2389G>T (p.Val797Leu), which is classified as Likely pathogenic by these guidelines and is in trans, from Service de Biochimie de Biologie Moléculaire, Hospices Civils de Lyon, France (VCI). LINK:https://erepo.genome.network/evrepo/ui/classification/CA043209/MONDO:0007750/013

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000038 ( 0 hom. )

Consequence

LDLR
NM_000527.5 missense

Scores

7
7
4

Clinical Significance

Pathogenic reviewed by expert panel P:16U:3

Conservation

PhyloP100: 2.65

Publications

7 publications found
Variant links:
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
LDLR Gene-Disease associations (from GenCC):
  • hypercholesterolemia, familial, 1
    Inheritance: AD, SD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 13 ACMG points.

PS4
For more information check the summary or visit ClinGen Evidence Repository.
PM1
For more information check the summary or visit ClinGen Evidence Repository.
PM2
For more information check the summary or visit ClinGen Evidence Repository.
PM3
For more information check the summary or visit ClinGen Evidence Repository.
PP1
For more information check the summary or visit ClinGen Evidence Repository.
PP4
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
NM_000527.5
MANE Select
c.337G>Ap.Glu113Lys
missense
Exon 4 of 18NP_000518.1P01130-1
LDLR
NM_001195798.2
c.337G>Ap.Glu113Lys
missense
Exon 4 of 18NP_001182727.1P01130-5
LDLR
NM_001195799.2
c.214G>Ap.Glu72Lys
missense
Exon 3 of 17NP_001182728.1P01130-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
ENST00000558518.6
TSL:1 MANE Select
c.337G>Ap.Glu113Lys
missense
Exon 4 of 18ENSP00000454071.1P01130-1
LDLR
ENST00000252444.10
TSL:1
c.595G>Ap.Glu199Lys
missense
Exon 4 of 18ENSP00000252444.6J3KMZ9
LDLR
ENST00000558013.5
TSL:1
c.337G>Ap.Glu113Lys
missense
Exon 4 of 18ENSP00000453346.1P01130-5

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152178
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000279
AC:
7
AN:
250568
AF XY:
0.0000368
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000383
AC:
56
AN:
1461178
Hom.:
0
Cov.:
33
AF XY:
0.0000468
AC XY:
34
AN XY:
726918
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33478
American (AMR)
AF:
0.0000224
AC:
1
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000139
AC:
12
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52722
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000369
AC:
41
AN:
1112004
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152178
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74340
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000482
AC:
2
AN:
41454
American (AMR)
AF:
0.00
AC:
0
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68036
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000203476), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000328
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.0000247
AC:
3

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
7
1
-
Hypercholesterolemia, familial, 1 (8)
4
1
-
Familial hypercholesterolemia (5)
4
-
-
not provided (4)
-
1
-
Cardiovascular phenotype (1)
1
-
-
Homozygous familial hypercholesterolemia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.65
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Pathogenic
0.18
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.86
D
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.20
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D
M_CAP
Pathogenic
0.56
D
MetaRNN
Pathogenic
0.87
D
MetaSVM
Uncertain
0.58
D
MutationAssessor
Uncertain
2.1
M
PhyloP100
2.7
PrimateAI
Benign
0.35
T
PROVEAN
Uncertain
-2.8
D
REVEL
Pathogenic
0.66
Sift
Benign
0.069
T
Sift4G
Uncertain
0.047
D
Polyphen
0.055
B
Vest4
0.49
MutPred
0.79
Gain of methylation at E113 (P = 0.003)
MVP
1.0
MPC
0.46
ClinPred
0.63
D
GERP RS
1.7
PromoterAI
-0.013
Neutral
Varity_R
0.47
gMVP
0.97
Mutation Taster
=1/99
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs769383881; hg19: chr19-11215919; API